Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 18, 1988 - Issue 4
13
Views
35
CrossRef citations to date
0
Altmetric
Original Article

Incidence of a subclinical fascioliasis on antipyrine clearance and metabolite excretion in sheep

, , , &
Pages 357-364 | Received 06 Apr 1987, Accepted 13 Nov 1987, Published online: 30 Sep 2009

References

  • Anderson P. H., Berret S., Brush P. J., Herbert C. N., Parfitt J. W., Patterson D. S. P. Biochemical indicators of liver injury in calves with experimental fascioliasis. The Veterinary Record 1977; 100: 43–45
  • Boulard C., Bouvry M., Argente G. Comparaison de la détection des foyers de fasciolose par test ELISA sur lactoserum et serum et par coproscopie. Annales de Recherches Vétérinaires 1985; 16: 363–368
  • Boxenbaum H. Interspecies pharmacokinetic scaling and the evolutionary-comparative paradigm. Drug Metabolism Reviews 1984; 15: 1071–1121
  • Boxenbaum H., Fertig J. B. Scaling of antipyrine intrinsic clearance of unbound drug in 15 mammalian species. European Journal of Drug Metabolism and Pharmacokinetics 1984; 9: 177–183
  • Breimer D. D. Interindividual variations in drug disposition. Clinical implications and methods of investigation. Clinical Pharmacokinetics 1983; 8: 371–377
  • Buppodom P., Koga N., Yamada H., Yoshimura H. Studies on rat liver cytochrome P-450s involved in the metabolism of antipyrine. Biochemical Pharmacology 1986; 35: 1404–1406
  • Danhof M., De Groot-Van Der Vis E., Breimer D. D. Assay of antipyrine and its primary metabolites in plasma, saliva and urine by HPLC, and some preliminary results in man. Pharmacology 1979a; 18: 210–223
  • Danhof M., Krom D. P., Breimer D. D. Studies on the different metabolic pathways of antipyrine in rats: Influence of phenobarbital and 3-methylcholanthrene treatment. Xennbiotica 1979b; 9: 695–702
  • Farrell G. C., Cooksley W. G. E., Powell L. W. Drug metabolism in liver disease: Activity of hepatic microsomal metabolizing enzymes. Clinical Pharmacology and Therapeutics 1979; 26: 483–492
  • Galtier P., Larrieu G., Beaune P. Characterization of the microsomal cytochrome P-450 species inhibited in rat liver in the course of fascioliasis. Biochemical Pharmacology 1986a; 35: 4345–4347
  • Galtier P., Larrieu G., Tufenkji A. E., Franc M. Incidence of experimental fascioliasis on the activity of drug-metabolizing enzymes in lamb liver. Drug Metabolism and Disposition 1986b; 14: 137–141
  • Gameel A. A. Fasciola Hepatica: Plasma ascorbic acid, plasma iron and iron-binding capacity in experimentally infected sheep. Zeitschrift für Parasitenkunde 1982; 65: 185–189
  • Gibaldi M., Perrier D. Pharmacokinetics2nd Ed. Marcel Dekker, Basel 1982
  • Gomeni R. Pharm- an interactive graphic program for individual and population pharmacokinetic parameter estimation. Computers in Biology and Medicine 1984; 14: 25–35
  • Huffman D. H., Shoeman D. W., Azarnoff D. L. Correlation of the plasma elimination of antipyrine and the appearance of 4-hydroxyantipyrine in the urine of man. Biochemical Pharmacology 1974; 23: 197–201
  • Mehta M. U., Venkataramanan R., Burckart G. J., Ptachcinski R. J., Yang S. L., Grey J. A., Van Thiel D. H., Starzl T. E. Antipyrine kinetics in liver disease and in liver transplantation. Clinical Pharmacology and Therapeutics 1986; 39: 372–377
  • Shargel L., Cheung W. M., Yu A. B. C. High pressure liquid chromatographic analysis of antipyrine in small plasma samples. Journal of Pharmaceutical Sciences 1979; 68: 1052–1053
  • Sotaniemi E. A., Pelkonen R. O., Puukka M. Measurement of hepatic drug-metabolizing enzyme activity in man. European Journal of Clinical Pharmacology 1980; 17: 267–274
  • Sunderman F. W. Trace elements. Chemical diagnosis of diseases, S. S. Brown, F. L. Mitchell, D. S. Young. Elsevier, Amsterdam 1979; 1010–1038
  • Symonds H. W., Mather D. L., Mallinson C. B., Hughes D. L. Bile flow, bile salt secretion and the excretion of iron, copper, zinc and manganese in the bile of calves infected with Fasciola hapatica. Research in Veterinary Science 1983; 35: 69–74
  • Teunissen M. W. E., Joeres R. P., Vermeulen N. P. E., Breimer D. D. Influence of 9-hydroxyellipticine and 3-methylcholanthrene treatment on in vitro antipyrine metabolite formation in rats. Xenobiotica 1983; 13: 223–231
  • Teunissen M. W. E., Spoelstra P., Koch C. W., Eeda B., Van Duyn W., Janssens A. R., Breimer D. D. Antipyrine clearance and metabolite formation in patients with alcoholic cirrhosis. British Journal of Clinical Pharmacology 1984; 18: 707–715
  • Toverud E. L., Boobis A. R., Brodie M. J., Murray S., Bennett P. N., Whitmarsh V., Davies D. S. Differential induction of antipyrine metabolism by rifampicin. European Journal of Clinical Pharmacology 1981; 21: 155–160
  • Tufenkji A. E., Alvinerie M., Houin G., Galtier P. Pharmacokinetics of sulfobromophthalein, lidocaine and indocyanine green in the course of subclinical fascioliasis in sheep. Research in Veterinary Science 1987; 43: 327–330

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.